Does RISANKIZUMAB-RZAA Cause Exostosis? 106 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Exostosis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.2% of all adverse event reports for RISANKIZUMAB-RZAA.
106
Reports of Exostosis with RISANKIZUMAB-RZAA
0.2%
of all RISANKIZUMAB-RZAA reports
0
Deaths
14
Hospitalizations
How Dangerous Is Exostosis From RISANKIZUMAB-RZAA?
Of the 106 reports, 14 (13.2%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Exostosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Exostosis?
ADALIMUMAB (2,008)
METHOTREXATE (968)
ETANERCEPT (918)
ABATACEPT (775)
TOCILIZUMAB (768)
LEFLUNOMIDE (743)
SULFASALAZINE (712)
DICLOFENAC (702)
TOFACITINIB (702)
CERTOLIZUMAB PEGOL (695)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Exostosis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA